Boothbay Fund Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Boothbay Fund Management’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-67,972	Closed	-$2.69M	–	1947
2024 Q1	$2.69M	Sell	67,972 -48,851	-42%	-$1.44M	0.05%	407
2023 Q4	$2.23M	Buy	+116,823	New	+$1.62M	0.06%	437
2021 Q3	–	Sell	-35,523	Closed	-$320K	–	2267
2021 Q2	$320K	Sell	35,523 -1,268	-3%	-$13.8K	0.01%	1236
2021 Q1	$390K	Buy	36,791 +26,361	+253%	+$329K	0.01%	1077
2020 Q4	$131K	Buy	+10,430	New	+$102K	﹤0.01%	1152

Boothbay Fund Management's ALPN Position: Q2 2024 in Review

Boothbay Fund Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 67,972 shares — an estimated $2.69M sold.

Boothbay Fund Management first reported a position in ALPN in Q4 2020 and held it in 5 quarters. The position peaked at $2.69M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Boothbay Fund Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Boothbay Fund Management sold 67,972 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $2.69M.
Boothbay Fund Management first reported a position in Alpine Immune Sciences Inc in Q4 2020 and held it in 5 quarters.
Boothbay Fund Management's Alpine Immune Sciences Inc position peaked at $2.69M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.